Showing 1–25 of 67 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | International Journal of Oncology ISSN: 1019-6439 / 1791-2423 | 🌐Greece | Q1 | CAS Tier 2 | 7.3 | 1.408Q1 | 111 | 124 | 0% | Spandidos Publications | Profile |
| 2 | Current Treatment Options in Oncology ISSN: 1527-2729 / 1534-6277Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 5.8 | 1.626Q1 | 48 | 114 | 0% | Springer US | Profile |
| 3 | Jco Oncology Practice ISSN: 2688-1527 / 2688-1535 | 🇺🇸United States | Q1 | CAS Tier 2 | 5.5 | 1.985Q1 | — | 227 | 6.4% | LIPPINCOTT WILLIAMS & WILKINS | Profile |
| 4 | Current Oncology Reports ISSN: 1523-3790 / 1534-6269Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 5.2 | 1.595Q1 | 52 | 139 | 0% | Springer US | Profile |
| 5 | Targeted Oncology ISSN: 1776-2596 / 1776-260X | 🇫🇷France | Q1 | CAS Tier 2 | 5.1 | 1.435Q1 | 35 | 67 | 2.3% | Springer International Publishing | Profile |
| 6 | Journal of Liquid Biopsy ISSN: 2950-1954 | 🌐International | Q2 | — | 5 | 0.832Q2 | — | — | N/A | ELSEVIER | Profile |
| 7 | Cancer Science ISSN: 1349-7006 / 1347-9032Top Tier | 🇯🇵Japan | Q2 | CAS Tier 2 | 4.9 | — | 123 | 426 | 2.2% | Wiley-Blackwell | Profile |
| 8 | Cancer Science ISSN: 1347-9032 / 1349-7006Top Tier | 🇯🇵Japan | Q2 | CAS Tier 2 | 4.9 | 1.509Q1 | 129 | 426 | 2.2% | Wiley-Blackwell | Profile |
| 9 | International Journal of Cancer ISSN: 0020-7136 / 1097-0215Top Tier | 🇨🇭Switzerland | Q2 | CAS Tier 2 | 4.9 | 1.901Q1 | 212 | 370 | 1.8% | Wiley-Liss Inc. | Profile |
| 10 | Translational Oncology ISSN: 1944-7124 / 1936-5233 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.9 | 1.383Q1 | 39 | 351 | 2.2% | Neoplasia Press | Profile |
| 11 | Cancer Imaging ISSN: 1470-7330 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.8 | 1.16Q1 | 40 | 66 | 2.9% | BioMed Central | Profile |
| 12 | Cancers ISSN: 2072-6694 | 🇨🇭Switzerland | Q2 | CAS Tier 2 | 4.8 | 1.41Q1 | 53 | 6,092 | 11.1% | MDPI (Basel, Switzerland) | Profile |
| 13 | JNCI Cancer Spectrum ISSN: 2515-5091 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.8 | 1.72Q1 | — | 104 | 0% | Oxford University Press | Profile |
| 14 | Neoplasia ISSN: 1522-8002 / 1476-5586 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | — | 117 | 111 | 1.6% | Neoplasia Press | Profile |
| 15 | Neoplasia ISSN: 1476-5586 / 1522-8002 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | 2.284Q1 | 115 | 111 | 1.6% | Neoplasia Press | Profile |
| 16 | Jco Precision Oncology ISSN: 2473-4284Top Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 4.7 | 2.082Q1 | — | 161 | 1.9% | LIPPINCOTT WILLIAMS & WILKINS | Profile |
| 17 | Medical Oncology ISSN: 1357-0560 / 1559-131X | 🇺🇸United States | Q2 | CAS Tier 3 | 4.7 | 0.963Q1 | 64 | 133 | 0% | Springer US | Profile |
| 18 | Oncologist ISSN: 1083-7159 / 1549-490XTop Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 4.7 | 1.96Q1 | 145 | 278 | 4.2% | AlphaMed Press | Profile |
| 19 | Oncology Reports ISSN: 1021-335X / 1791-2431 | 🌐Greece | Q2 | CAS Tier 3 | 4.7 | 0.887Q2 | 84 | 326 | 2.6% | Spandidos Publications | Profile |
| 20 | Oncology Research ISSN: 0965-0407 / 1555-3906 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.6 | 1.102Q1 | 52 | 27 | 0% | Cognizant Communication Corporation | Profile |
| 21 | Molecular Oncology ISSN: 1574-7891 / 1878-0261Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.5 | 1.738Q1 | 71 | 239 | 2% | John Wiley and Sons Ltd | Profile |
| 22 | Cancer Research and Treatment ISSN: 1598-2998 / 2005-9256 | 🌐South Korea | Q2 | CAS Tier 3 | 4.2 | 1.462Q1 | 28 | 119 | 4.9% | Korean Cancer Association | Profile |
| 23 | Journal of Gynecologic Oncology ISSN: 2005-0380 / 2005-0399 | 🌐South Korea | Q1 | CAS Tier 2 | 4.2 | 1.256Q1 | 30 | 64 | 5.9% | Korean Society of Gynecologic Oncology and Colposcopy | Profile |
| 24 | BMC Cancer ISSN: 1471-2407Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.1 | 1.172Q2 | 111 | 1,321 | 2.9% | BioMed Central | Profile |
| 25 | Clinical Lymphoma Myeloma & Leukemia ISSN: 2152-2650 / 2152-2669 | 🇺🇸United States | Q1 | CAS Tier 3 | 4.1 | 0.615Q2 | — | 230 | 3.7% | Cancer Media Group | Profile |